Avenda Health

United States - Culver City, California

• 30/08/2022
• Series B
• $10,000,000

1 in 7 men will be diagnosed with prostate cancer in their lifetime, and the current standard of care in treatment significantly impairs quality of life due to imprecision.

Avenda Health is creating a more personalized future of prostate cancer care. We've built a platform that uses deep learning to map a patient's cancer in 3D, giving physicians precise information and the confidence to make care decisions. This is paired with a proprietary targeted ablative therapy that can treat patients in a doctors office under local anesthesia. Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.

Related People

Shyam NatarajanCo Founder

United States - Los Angeles, California

Focused on improving clinical outcomes and patient care in urology and beyond.

Leading a clinical-stage AI healthcare startup that is creating a more personalized future of prostate cancer care. Previously led an NIH-funded lab focusing on image-guided cancer interventions at UCLA with a background in software engineering.

LinkedIn https://www.linkedin.com/in/shyam-natarajan-71014033/